Both in Biotechnology
Hemab Therapeutics Holdings vs Maze Therapeutics
Over the past year COAG returned +14.4% and MAZE returned +35.7%; their daily moves had a correlation of 0.28.
COAG +14.4% MAZE +35.7%Growth of $1, one year, split-adjusted
| Metric | COAG | MAZE |
|---|---|---|
| Price | $45.09 | $33.38 |
| Market cap | $2.11B | $1.85B |
| Today | +4.62% | +3.50% |
| 1 month | +58.9% | +26.3% |
| 6 months | — | +26.1% |
| Year to date | — | −19.4% |
| 1 year | — | +0.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 92.7× |
| Net cash | $457.5M | $372.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 67.7% |
| Short % of float | 20.4% | 18.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).